Subunit Vaccine Production in CHO cells: Development of an Efficacious Ebola Virus Vaccine Candidate Authors Florian M. Wurm PhD, Prof. Emeri. Chief Scientific Officer, Founder Divor Kiseljak PhD Director of Process Science 20th April 2020 | Last updated: 3rd August...
White Paper: CHO Quasispecies – Implications for Manufacturing Processes Now Available The White Paper CHO Quasispecies – Implications for Manufacturing Processes is now freely available for viewing on our website. First published in Processes Journal in 2013, it has...
CHO Quasispecies – Implications for Manufacturing Processes AbstractChinese hamster ovary (CHO) cells are a source of multi-ton quantities of protein pharmaceuticals. They are, however, immortalized cells, characterized by a high degree of genetic and phenotypic...
Talks: Single-Use Bioreactors and Disposable Process Materials: How-To and Issues @ Disposable Solutions Berlin, Feb 19 Disposable materials in bioprocessing and single-use bioreactors have become widely used standards in R&D at small scale as well as cGMP based...
Cloning of CHO Cells, Productivity and Genetic Stability – a Discussion AbstractWhile many perceive mammalian cell culture-based manufacturing for biopharmaceuticals an established technology, numerous open questions remain to be solved. Genetic diversity and mutation...
